Daniel Lopez MD

All Posts

• Belviq: A Novel Multipotential Therapeutic and Preventative Anti-Obesity Medication

  By Daniel P. Lopez, M.D., F.A.C.O.G. - September 27, 2012 | Tickers: ARNA, VVUS

  The purpose of this article is to provide evidence of the multipotential uses of Belviq and the blockbuster investment potential this company provides as a novel new drug in the treatment of obesity and the prevention of disorders associated with it.